|
|
Volumn 295, Issue 5564, 2002, Pages 2465-2468
|
|
Molecular determinants for the tissue specificity of SERMs
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELLS;
GENES;
GENETIC ENGINEERING;
TUMORS;
MOLECULAR DETERMINANTS;
TISSUE;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
STEROID RECEPTOR COACTIVATOR 1;
TAMOXIFEN;
CANCER;
DRUG DEVELOPMENT;
ARTICLE;
BREAST CANCER;
BREAST CELL;
CELL TYPE;
CONTROLLED STUDY;
ENDOMETRIUM CELL;
ESTROGEN ACTIVITY;
GENE EXPRESSION;
GENE TARGETING;
HUMAN;
HUMAN CELL;
PRIORITY JOURNAL;
PROMOTER REGION;
TISSUE SPECIFICITY;
BREAST;
BREAST NEOPLASMS;
CELL CYCLE;
DNA-BINDING PROTEINS;
ENDOMETRIAL NEOPLASMS;
ENDOMETRIUM;
ESTRADIOL;
FEMALE;
GENE EXPRESSION REGULATION;
GENE SILENCING;
GENES, MYC;
HISTONE ACETYLTRANSFERASES;
HISTONE DEACETYLASES;
HUMANS;
INSULIN-LIKE GROWTH FACTOR I;
ORGAN SPECIFICITY;
PROMOTER REGIONS (GENETICS);
RALOXIFENE;
RECEPTORS, ESTROGEN;
REPRESSOR PROTEINS;
RESPONSE ELEMENTS;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
TAMOXIFEN;
TRANSCRIPTION FACTORS;
TRANSCRIPTION, GENETIC;
TUMOR CELLS, CULTURED;
|
|
EID: 0037192501
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1068537 Document Type: Article |
|
Times cited : (1019)
|
|
References (30)
|
